Biotech and Pharmaceuticals

“This medicine could be one of our largest medicines in history,” Novartis CEO Vas Narasimhan told CNBC on…

Eli Lilly on Thursday reported third-quarter earnings and revenue that blew past estimates and hiked its full-year sales…

UnitedHealth Group signage on the floor of the New York Stock Exchange on April 21, 2025. Michael Nagle…

People who switched from obesity injections to Novo‘s new Wegovy pill continued to lose weight after three months,…

Two Indian nationals have been charged in federal court in Florida with an alleged conspiracy to smuggle counterfeit…

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…

An Obamacare sign is displayed outside an insurance agency on Nov. 12, 2025, in Miami. Joe Raedle |…

Eli Lilly CEO Dave Ricks told CNBC on Monday that 700,000 new seniors have started GLP-1 treatments since…

Eli Lilly CEO Dave Ricks told CNBC on Monday that one-third of new GLP-1 pill patients are taking…

Novo Nordisk on Monday said it is rebranding its name to “Novo” and updating its corporate culture, as…

Johnson & Johnson is diving head-first into the deep end of the competitive robotic surgery market. The payoff…

Eli Lilly and Company’s logo is displayed during a press conference in Houston, Texas, U.S., Sept. 23, 2025.…

Novartis remibrutinib MS drug faces efficacy questions